BPG is committed to discovery and dissemination of knowledge
Articles in Press
5/29/2026 6:45:13 AM | Browse: 6 | Download: 0
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Basic Study |
| Article Title |
OH-CATH30 targets CD40 to suppress NF-κB signaling and promote arachidonic acid metabolic reprogramming in acute pancreatitis
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Ke-Liang Li, Yue Zhao, Wei-Jie Shang, Qi-Hang Guo, Hai-Tao Liu, Ji-Yu Zhang, Xue-Lin Jia and Bing-Rong Liu |
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Zhongyuan Talent Program |
ZYYCYU202012113 |
| Key R&D Program of Henan Province |
231111311600 |
| Outstanding Foreign Scientist Studio Project of Henan Province |
GZS2020006 |
|
| Corresponding Author |
Bing-Rong Liu, Department of Gastroenterology and Hepatology, The First Affiliated Hospital of Zhengzhou University, No. 1 Jianshe East Road, Zhengzhou 450052, Henan Province, China. fccliubr@zzu.edu.cn |
| Key Words |
Acute pancreatitis; OH-CATH30; CD40; Nuclear factor-kappa B signaling; Macrophage polarization; Anti-inflammatory peptide; Arachidonic acid metabolism |
| Core Tip |
This study identifies CD40 as a pivotal therapeutic target in acute pancreatitis. The antimicrobial peptide OH-CATH30 binds to CD40 and suppresses the CD40-tumor necrosis factor receptor-associated factor 6-transforming growth factor beta-activated kinase 1-nuclear factor-kappa B signaling cascade. This inhibition drives macrophage polarization from pro-inflammatory M1 to anti-inflammatory M2 phenotype and corrects arachidonic acid metabolic dysregulation. These findings establish CD40 as a central node that links inflammatory signaling and metabolic reprogramming in acute pancreatitis. Thus, OH-CATH30 is a promising multi-functional therapeutic candidate for this devastating inflammatory disease. |
| Citation |
Li KL, Zhao Y, Shang WJ, Guo QH, Liu HT, Zhang JY, Jia XL, Liu BR. OH-CATH30 targets CD40 to suppress NF-κB signaling and promote arachidonic acid metabolic reprogramming in acute pancreatitis. World J Gastroenterol 2026; In press |
 |
Received |
|
2026-04-01 03:44 |
 |
Peer-Review Started |
|
2026-04-01 03:45 |
 |
First Decision by Editorial Office Director |
|
2026-04-10 10:28 |
 |
Return for Revision |
|
2026-04-10 10:28 |
 |
Revised |
|
2026-04-25 06:07 |
 |
Publication Fee Transferred |
|
2026-04-29 04:05 |
 |
Second Decision by Editor |
|
2026-05-29 03:01 |
 |
Second Decision by Editor-in-Chief |
|
|
 |
Final Decision by Editorial Office Director |
|
2026-05-29 06:45 |
 |
Articles in Press |
|
2026-05-29 06:45 |
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
|
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
©Author(s) (or their employer(s)) 2026. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc. |
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.